Sort
11,323 grants matching “glioblastoma”
Targeting cancer-associated cohesin alterations
$49,152Joshua Aaron Regal · University Of British Columbia · F32 · FY2016 · CA
Targeting Radiation Resistance in Glioblastoma Stem Cells
$49,124Jialiang Wang · Vanderbilt University Medical Center · R01 · FY2015 · CA
Characterization of GATOR1 signaling to mTORC1 and its role in cancer
$49,044Rachel Laura Wolfson · Harvard Medical School · F30 · FY2017 · CA
Towards the automation of MR spectroscopic imaging in patients with glioblashoma
$49,044Saumya Gurbani · Emory University · F30 · FY2017 · CA
Systemic EGFRvIII-targeted bispecific antibody as immunotherapy for glioblastoma
$49,044Patrick C Gedeon · Duke University · F30 · FY2017 · CA
The role of glioblastoma derived activated leukocyte cell adhesion molecule in peripheral monocyte PD-L1 induction and immunosuppression
$49,044Jonathan Balquiedra Lamano · Northwestern University At Chicago · F30 · FY2017 · CA
Targeted drug delivery system to overcome blood-brain barrier and therapeutic resistance to current standard of care in Glioblastoma
$49,006Meser M. Ali · Henry Ford Health System · R01 · FY2024 · CA
Genetic and epigenetic mechanisms of glioblastoma invasion and their therapeutic implication
$48,974Gretchen Irella Long · Yale University · F31 · FY2024 · NS
Monosynaptic tracing defines circuit connectivity of human high-grade glioma in the adult mouse brain
$48,974Yusha Sun · University Of Pennsylvania · F31 · FY2024 · NS
Dissecting the tumor cell-immune TME axis to identify therapeutically actionable vulnerabilities that potentiate immunotherapy in GBM
$48,974Amanda Johnson · Johns Hopkins University · F99 · FY2024 · CA
Automated imaging analysis tools to guide clinical decision making in brain tumor patients
$48,974Karthik Ramesh · Emory University · F31 · FY2024 · CA
In vivo regulators of TERT promoter mutant glioblastoma
$48,914Alexandra M Amen · University Of California Berkeley · F32 · FY2020 · CA
Influence of Anti-Angiogenic Therapy on Drug Delivery to Brain Tumors
$48,893William F Elmquist · University Of Minnesota · R01 · FY2013 · NS
Therapeutic Engineered Stem Cells as a New Adjuvant Therapy for Non-Small Cell Lung Cancer Brain Metastases
$48,776Alison R. Mercer-Smith · Univ Of North Carolina Chapel Hill · F30 · FY2022 · CA
Lung squamous cell carcinoma subtypes: genomic abberations and clinical detection
$48,752Matthew Devin Wilkerson · Univ Of North Carolina Chapel Hill · F32 · FY2009 · CA
Molecular Analysis and Role of RGS6 as a Novel Growth Suppressor
$48,750Rory A. Fisher · University Of Iowa · R01 · FY2008 · GM
Understanding expression and signaling of sex hormone receptors in brain cancers
$48,717Martha Addison Dwyer Cady · University Of California, San Francisco · F99 · FY2024 · CA
Translational Therapeutics Research Program (TT)
$48,694David P Carbone · Ohio State University · P30 · FY2020 · CA
AP 3. Chemistry and Drug Discovery
$48,685Gisela P Concepcion · University Of Utah · U19 · FY2015 · TW
Molecular Oncology Research Program
$48,623Justin D. Lathia · Case Western Reserve University · P30 · FY2021 · CA
PHARMACOKINETICS OF SODIUM BOROCAPTATE IN ANAPLASTIC ASTROCYTOMA
$48,578Ohio State University · M01 · FY2000 · RR
The role of glioblastoma derived activated leukocyte cell adhesion molecule in peripheral monocyte PD-L1 induction and immunosuppression
$48,576Jonathan Balquiedra Lamano · Northwestern University At Chicago · F30 · FY2016 · CA
Overcoming Temozolomide Resistance using MGMT-targeting Spherical Nucleic Acids
$48,576Timothy L Sita · Northwestern University · F30 · FY2016 · CA
Human cytomegalovirus in the promotion of glioblastoma multiforme pathogenesis
$48,576Michael James Strong · Tulane University Of Louisiana · F30 · FY2016 · CA
OCT to Distinguish b/t Tumor & Non-Tumor Tissue in Infiltrating Brain Cancer
$48,576Carmen Kut · Johns Hopkins University · F30 · FY2016 · CA